Digital Frontiers Health 2024: Day Two We are back for Day Two of Frontiers Health, coming to you live from the heart of Berlin!
Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One!
Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
